Cardiac failure chronic+1
Not recruitingStudy on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction
Italy- Participants:18–64 years · 65+ years
- Substances:Vericiguat
- Sponsor:Bayer AG
Rare diseases
Investigational molecules
Locations
Back to Italy554 clinical trials in Brescia, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on metastatic colorectal cancer, chronic myeloid leukemia, and renal cell carcinoma. Studies evaluate novel combination therapies and treatment strategies for advanced cancer cases.
Research includes evaluation of targeted therapies and immunotherapy approaches.
Comprehensive studies addressing Parkinson's disease, Frontotemporal Dementia, and Alzheimer's-related psychosis. Research focuses on novel therapeutic approaches and disease-modifying treatments.
Trials aim to improve patient outcomes and quality of life.
Groundbreaking research in Psoriatic Arthritis, Crohn's Disease, and Sjögren's Syndrome. Studies evaluate biological therapies and innovative treatment approaches.
Focus on developing targeted treatments for chronic conditions.
Studies addressing heart failure prevention and cardiovascular disease. Research evaluates new combination therapies and preventive approaches.
Emphasis on preventive strategies and innovative treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.